Edition:
United Kingdom

Insider Trading: Constellation Pharmaceuticals Inc (CNST.OQ)

CNST.OQ on NASDAQ Stock Exchange Global Select Market

6.68USD
23 Aug 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$6.68
Open
$7.49
Day's High
$7.49
Day's Low
$6.47
Volume
10,464
Avg. Vol
20,715
52-wk High
$14.04
52-wk Low
$4.01

All Insider Trades
Trading Date Name Title Type Shares Traded Price
13 Dec 2018

Senderowicz (Adrian M)

Officer Buy 9,083 $5.51
13 Dec 2018

Senderowicz (Adrian M)

Officer Buy 6,801 $5.51
22 Aug 2018

Third Rock Ventures L P

Beneficial Owner of More than 10% Class Buy 51,032 $1.55
23 Jul 2018

Column Group L.P.

Beneficial Owner of More than 10% Class Buy 4,666,888 $0.00
23 Jul 2018

Evnin (Anthony B)

Director and Beneficial Owner Buy 2,385,902 $0.00
23 Jul 2018

Evnin (Anthony B)

Director and Beneficial Owner Buy 133,334 $15.00
23 Jul 2018

Svennilson Peter

Director and Beneficial Owner Buy 4,666,888 $0.00
23 Jul 2018

Third Rock Ventures L P

Beneficial Owner of More than 10% Class Buy 2,705,334 $0.00
23 Jul 2018

Third Rock Ventures L P

Beneficial Owner of More than 10% Class Buy 266,667 $15.00
23 Jul 2018

Svennilson Peter

Beneficial Owner of More than 10% Class Buy 345,783 $0.00
23 Jul 2018

Spur Ventures II, LP

Beneficial Owner of More than 10% Class Buy 349,853 $0.00
23 Jul 2018

Svennilson Peter

Beneficial Owner of More than 10% Class Buy 158,960 $0.00
23 Jul 2018

OrbiMed Advisors, L.L.C.

Beneficial Owner of More than 10% Class Buy 317,921 $0.00
23 Jul 2018

Topspin fund L.P

Beneficial Owner of More than 10% Class Buy 445,270 $0.00
23 Jul 2018

Alexandria Venture Investments, L.L.C

Beneficial Owner of More than 10% Class Buy 66,667 $15.00
23 Jul 2018

Column Group L.P.

Beneficial Owner of More than 10% Class Buy 79,155 $0.00
23 Jul 2018

OrbiMed Advisors, L.L.C.

Beneficial Owner of More than 10% Class Buy 100,000 $15.00
23 Jul 2018

FLYNN JAMES E

Beneficial Owner of More than 10% Class Buy 635,843 $0.00
23 Jul 2018

Topspin fund L.P

Beneficial Owner of More than 10% Class Buy 54,770 $0.00
23 Jul 2018

FLYNN JAMES E

Beneficial Owner of More than 10% Class Buy 200,000 $15.00
23 Jul 2018

Precision Onco Ltd

Beneficial Owner of More than 10% Class Buy 317,921 $0.00
23 Jul 2018

Mountain Berg Ltd

Beneficial Owner of More than 10% Class Buy 174,926 $0.00
23 Jul 2018

OrbiMed Advisors, L.L.C.

Beneficial Owner of More than 10% Class Buy 100,000 $15.00
23 Jul 2018

Topspin fund L.P

Beneficial Owner of More than 10% Class Buy 1,277,984 $0.00
23 Jul 2018

Alexandria Venture Investments, L.L.C

Beneficial Owner of More than 10% Class Buy 149,637 $0.00

Institutional Holders

% Shares Owned: 91.51%
# of Holders: 75
Total Shares Held: 23,629,987
3 Mo. Net Change: 354,614
# New Positions: 16
# Closed Positions: 8
# Increased Positions: 34
# Reduced Positions: 26
# Net Buyers: 8

Officers & Directors

Name Age Since Current Position

Mark Goldsmith

56 2009 Independent Chairman of the Board

Jigar Raythatha

41 2017 President, Chief Executive Officer, Director

Emma Reeve

58 2017 Chief Financial Officer, Senior Vice President

Brenda Sousa

54 2017 Senior Vice President of Human Resources

Brad Prosek

2017 Senior Vice President, Corporate Development

Adrian Senderowicz

55 2017 Senior Vice President and Chief Medical Officer

Robert Sims

44 2017 Senior Vice President of Research

Patrick Trojer

45 2017 Senior Vice President, EZH2, Franchise and Head of Translational Sciences

Jessica Christo

2019 Chief Product Development Officer

James Audia

62 2017 Director

Scott Braunstein

55 2019 Independent Director

Anthony Evnin

77 2008 Independent Director

Steven Hoerter

48 2018 Independent Director

Peter Svennilson

56 2016 Independent Director

Robert Tepper

63 2008 Independent Director

Elizabeth Trehu

58 2018 Independent Director

Ronald Aldridge

2017 IR Contact Officer